Screener
Madrigal Pharmaceuticals, Inc. MDGL Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.
Plus components not separately reported this period.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s total debt?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported total debt of $377.85M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s total debt changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s total debt increased by 178.8% year-over-year, from $135.55M to $377.85M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s total debt?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s total debt has grown at a 238.2% compound annual growth rate (CAGR), from $786K to $347.63M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude